Nature Medicine - Retraction Note: Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial

Subscription and open access journals from Sage, the world's leading independent academic publisher.

When I was diagnosed with cancer, I set out to understand why a single pill of Revlimid cost the same as a new iPhone. I’ve covered high drug prices as a reporter for years. What I discovered shocked ...

KEYNOTE-991 trial shows no survival benefit from adding pembrolizumab to enzalutamide and ADT in mHSPC.

The use of antidepressants — particularly selective serotonin re-uptake inhibitors (SSRIs) — are associated with a “statistically substantial increased risk” of postural hypotension (PH) in older…

We are already counting down to the 2012 Eurovision Song Contest in Baku. We do that by looking back to recent editions of Europe's favorite TV show. This time we go to 2007, when the contest was held...

The new custom analysis feature on OpenPrescribing Hospitals.

Classification: OfficialPublication reference: PRN01515 To: cc. Dear colleagues, Update on Independent Prescribing in Community Pharmacy Pathfinder Programme From September 2026, all newly qualified p...